2052969-18-1

Upacicalcet sodium is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1].

-20°C, away from moisture

[1] Hoy SM. Upacicalcet: First Approval. Drugs. 2021;81(13):1593-1596. DOI:10.1007/s40265-021-01578-y